Earnings Feed
Start Free
Home/Filings/4/0000899243-21-019515
4//SEC Filing

Versant Ventures IV, LLC 4

Accession 0000899243-21-019515

CIK 0001720725other
View on SEC.govCompany Profile

Filed

May 13, 8:00 PM ET

Accepted

May 14, 4:45 PM ET

Size

29.4 KB

Accession

0000899243-21-019515

Insider Transaction Report

Form 4
Period: 2021-05-12
Oyster Point Pharma, Inc.OYST
Versant Ventures VI GP, L.P.
10% Owner
Transactions
  • Other

    Common Stock

    2021-05-12−320,340→ 1,361,590 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-05-12+82,486→ 82,486 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-05-12−82,486→ 0 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-05-12−2,018→ 8,430 total(indirect: See Footnotes)
Holdings

  • Common Stock

    (indirect: See Footnotes)
    1,003,658

  • Common Stock

    2,236,888
Versant Ventures VI GP-GP, LLC
10% Owner
Transactions
  • Other

    Common Stock

    2021-05-12−82,486→ 0 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-05-12−2,018→ 8,430 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-05-12−320,340→ 1,361,590 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-05-12+82,486→ 82,486 total(indirect: See Footnotes)
Holdings

  • Common Stock

    2,236,888

  • Common Stock

    (indirect: See Footnotes)
    1,003,658
Versant Vantage I, L.P.
10% Owner
Transactions
  • Other

    Common Stock

    2021-05-12+82,486→ 82,486 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-05-12−2,018→ 8,430 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-05-12−320,340→ 1,361,590 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-05-12−82,486→ 0 total(indirect: See Footnotes)
Holdings

  • Common Stock

    2,236,888

  • Common Stock

    (indirect: See Footnotes)
    1,003,658
Versant Vantage I GP, L.P.
10% Owner
Transactions
  • Other

    Common Stock

    2021-05-12−320,340→ 1,361,590 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-05-12+82,486→ 82,486 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-05-12−82,486→ 0 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-05-12−2,018→ 8,430 total(indirect: See Footnotes)
Holdings

  • Common Stock

    2,236,888

  • Common Stock

    (indirect: See Footnotes)
    1,003,658
Versant Vantage I GP-GP, LLC
10% Owner
Transactions
  • Other

    Common Stock

    2021-05-12−320,340→ 1,361,590 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-05-12+82,486→ 82,486 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-05-12−82,486→ 0 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-05-12−2,018→ 8,430 total(indirect: See Footnotes)
Holdings

  • Common Stock

    2,236,888

  • Common Stock

    (indirect: See Footnotes)
    1,003,658
Versant Venture Capital VI, L.P.
10% Owner
Transactions
  • Other

    Common Stock

    2021-05-12−320,340→ 1,361,590 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-05-12+82,486→ 82,486 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-05-12−82,486→ 0 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-05-12−2,018→ 8,430 total(indirect: See Footnotes)
Holdings

  • Common Stock

    2,236,888

  • Common Stock

    (indirect: See Footnotes)
    1,003,658
Versant Ventures IV, LLC
10% Owner
Transactions
  • Other

    Common Stock

    2021-05-12−320,340→ 1,361,590 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-05-12+82,486→ 82,486 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-05-12−2,018→ 8,430 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-05-12−82,486→ 0 total(indirect: See Footnotes)
Holdings

  • Common Stock

    (indirect: See Footnotes)
    1,003,658

  • Common Stock

    2,236,888
Versant Venture Capital IV, L.P.
10% Owner
Transactions
  • Other

    Common Stock

    2021-05-12+82,486→ 82,486 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-05-12−320,340→ 1,361,590 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-05-12−82,486→ 0 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-05-12−2,018→ 8,430 total(indirect: See Footnotes)
Holdings

  • Common Stock

    2,236,888

  • Common Stock

    (indirect: See Footnotes)
    1,003,658
Versant Side Fund IV, L.P.
10% Owner
Transactions
  • Other

    Common Stock

    2021-05-12−320,340→ 1,361,590 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-05-12+82,486→ 82,486 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-05-12−82,486→ 0 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-05-12−2,018→ 8,430 total(indirect: See Footnotes)
Holdings

  • Common Stock

    2,236,888

  • Common Stock

    (indirect: See Footnotes)
    1,003,658
Footnotes (9)
  • [F1]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital IV, L.P. ("Versant IV") to its partners.
  • [F2]Shares held by Versant IV. Versant Ventures IV, LLC ("Versant Ventures IV") is the sole general partner of Versant IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant IV. Each of Versant Ventures IV and William J. Link disclaims beneficial ownership of the shares held by Versant IV, except to the extent of their respective pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly, files separate Section 16 reports.
  • [F3]Represents a change in the form of ownership of Versant Ventures IV by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant IV.
  • [F4]Shares held by Versant Ventures IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant Ventures IV. William J. Link disclaims beneficial ownership of the shares held by Versant Ventures IV, except to the extent of his pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly files separate Section 16 reports.
  • [F5]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures IV, to its members.
  • [F6]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Side Fund IV, L.P. ("Versant Side Fund IV") to its partners.
  • [F7]Shares held by Versant Side Fund IV. Versant Ventures IV is the sole general partner of Versant Side Fund IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant Side Fund IV. Each of Versant Ventures IV and William J. Link disclaims beneficial ownership of the shares held by Versant Side Fund IV, except to the extent of their respective pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly, files separate Section 16 reports.
  • [F8]Shares held by Versant Venture Capital VI, L.P. ("Versant VI"). Versant Ventures VI GP-GP, LLC ("Versant Ventures VI GP-GP") is the sole general partner of Versant Ventures VI GP, L.P. ("Versant Ventures VI GP") and Versant Ventures VI GP is the sole general partner of Versant VI. Clare Ozawa, a member of the Issuer's board of directors, is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI. Each of Versant Ventures VI GP-GP, Versant Ventures VI GP and Clare Ozawa disclaims beneficial ownership of the shares held by Versant VI, except to the extent of their respective pecuniary interests therein. Clare Ozawa is a director of the Issuer and, accordingly files separate Section 16 reports.
  • [F9]Shares held by Versant Vantage I, L.P. ("Versant Vantage"). Versant Vantage I GP-GP, LLC ("Versant Vantage I GP-GP") is the sole general partner of Versant Vantage I GP, L.P. ("Versant Vantage I GP") and Versant Vantage I GP is the sole general Partner of Versant Vantage. Clare Ozawa, a member of the Issuer's board of directors, is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage. Each of Versant Vantage I GP-GP, Versant Vantage I GP, and Clare Ozawa disclaims beneficial ownership of the shares held by Versant Vantage, except to the extent of their respective pecuniary interests therein. Clare Ozawa is a director of the Issuer and, accordingly files separate Section 16 reports.

Documents

1 file

Issuer

Oyster Point Pharma, Inc.

CIK 0001720725

→
Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001456589

Filing Metadata

Form type
4
Filed
May 13, 8:00 PM ET
Accepted
May 14, 4:45 PM ET
Size
29.4 KB
View on SEC.gov